FDA Approves Contrave Weight Control Drug
Dr. Jennifer Ashton explains how the new drug works and the possible health risks.
Why Falling Gas Prices Have Further to Go
Morning Money Memo… There’s good news about the cost of energy: It’s getting cheaper. The cost of oil has been falling for weeks on global markets. West Texas crude is now just under $91 a barrel. The International Energy Agency has again cut its oil...
'Growing Pains' Star Reveals Past Battle With Alcoholism
"Growing Pains" star Jeremy Miller was like many actors who hit it big at a young age and succumbed to the temptations of alcohol and underage partying. "I'm glad I did not own a gun, because I hated myself so thoroughly that I would have done something very stupid," Miller told Entertainment
FDA Panel Gives Nod to New Diet Drug Lorqess
SILVER SPRING, Md. -- An FDA advisory committee has voted 18-4, with one abstention, in favor of approving Lorqess as the first new weight-loss drug in more than a decade. The FDA's Endocrinologic and Metabolic Drugs Advisory Committee on Thursday afternoon voted that the benefits of Lorqess
Qnexa Ruling Renews Debate About Its Risks and Benefits
The decision by a federal advisory panel to recommend Qnexa for approval by the U.S. Food and Drug Administration is drawing praise and criticism from obesity and diet experts, reflecting a still-hot debate on the need for additional tools to treat obesity. The 20 to 2 decision recommending
Baseball MVP Josh Hamilton Suffers Addiction Relapse
Texas Rangers’ outfielder Josh Hamilton, the 2010 American League MVP who has battled alcohol and drug addictions for over a decade, has suffered a relapse with alcohol. ESPN reports that Hamilton, 30, drank alcohol at Sherlock’s Pub and Grill in Dallas on Monday. Teammate Ian...
Makers of Obesity Pills Again Try to Win FDA Approval
Companies developing three different weight-loss pills that were rejected by the U.S. Food and Drug Administration still believe they can eventually bring the products to market, though the firms are taking different approaches to winning over the agency. Vivus Inc., which is developing an oral
The Beginning of the End of Residential Drug and Alcohol Treatment?
In my specialty as an addiction psychiatrist, I have often advocated for residential treatment when unremitting drug and alcohol problems persist because other, less intensive, services have failed. That may soon change. Over the past two years, I've witnessed a worrisome trend: the medicalization
Prescription Painkillers: Companies Attempt Abuse-Proof Opioids
When the oxycodone brand called OxyContin was introduced in the late 1990s, its maker claimed that the drug's controlled-release mechanism would make it less likely to be abused. The idea was that if it released its opioid slowly, rather than all at once, abusers wouldn't find the immediate rush